Home / Products / Questhorse

Print page content Print
Increase text size Decrease text size
Text Size

DEWORM YOUR HORSE IN ONE DOSE WITH QUEST® or QUEST® PLUS

Just one dose of QUEST® or QUEST® PLUS Gel treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient — praziquantel — for efficacy against tapeworms. The American Association of Equine Practitioners (AAEP) recommends tapeworm treatment in the late fall or early winter after tapeworm transmission ends due to cold weather.1

One syringe of QUEST or QUEST PLUS now treats up to 1,500 pounds. Both dewormers remain the same trusted formulations. Use a scale or weight tape prior to each deworming to help ensure an accurate dose for your horse.

Since 2008, veterinarians and horse owners have purchased more than 16 million tubes of QUEST and QUEST PLUS, a testament to horse owners' trust in QUEST and QUEST PLUS.2

EFFECTIVE AGAINST KEY EQUINE PARASITES

Small strongyles are the key parasite of concern for adult horses.1 This equine parasite has shown widespread resistance to fenbendazole. Moxidectin, the active ingredient in QUEST and QUEST PLUS, continues to show efficacy.3,*

LONG LASTING PARASITE SUPPRESSION

QUEST and QUEST PLUS are the only FDA-approved products to suppress the production of small strongyle eggs, and a study showed egg suppression persisted for 90 days.2 This residual parasite control reduces pasture contamination and provides a period of protection from reinfection for horses and ponies.

APPROVED FOR BREEDING HORSES

QUEST and QUEST PLUS are proven safe for use in a variety of horses. QUEST and QUEST PLUS are the only products approved to treat encysted small strongyles in breeding mares.

Purchase QUEST and QUEST PLUS from your equine veterinarian or retailer. Prior to purchasing a dewormer, work with your veterinarian to complete a fecal egg count (FEC) test for your horse.

Do not use QUEST Gel or QUEST PLUS Gel in foals less than 6 months of age or in sick, debilitated and underweight horses. Do not use in other animal species, as severe adverse reactions, including fatalities in dogs, may result.

1American Association of Equine Practitioners. Parasite Control Guidelines. https://aaep.org/guidelines/parasite-control-guidelines. Accessed June 11, 2018.
2Data on file, Business Objects sales data for QUEST, QUEST PLUS, ANTHELCIDE EQ, STRONGID Paste as of June 11, 2018, Zoetis Inc.
3Mason ME, Voris ND, Ortis HA, et al. Comparison of a single dose of moxidectin and a five-day course of fenbendazole to reduce and suppress cyathostomin fecal egg counts in a herd of embryo transfer-recipient mares. J Am Vet Med Assoc. 2014;245(8):944-951.*
* This study compared QUEST (moxidectin) Gel with Panacur® Powerpac (fenbendazole).

QST-00039R1

Panacur is a registered trademark of Merck Animal Health.

EquiMAX is a registered trademark of Virbac S.A. Corporation. Panacur is a registered trademark of Merck Animal Health. Safe-Guard is a registered trademark of Intervet Inc. or an affiliate. Eqvalan, Zimecterin and Zimecterin Gold are registered trademarks of Merial Limited.

Image Chart

CONTACT US

1-888-963-8471

Mon–Fri, 8:30am–6:30pm ET

zoetis logo United States flag United States

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.